Understanding how Notch2 influences B cell growth and antibody production
Notch2 Amplification of B Cell Division and Differentiation Fates
This study is looking at how a specific pathway in our immune system helps B cells, which are important for making antibodies, grow and change into cells that can fight off viruses like SARS-CoV-2, with the hope of finding better ways to create vaccines.
Quick facts
| Grant type | Fellowship grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Pennsylvania NIH-funded |
| Lab location | 1 site (Philadelphia, United States) |
| Project ID | NIH-10900500 on NIH RePORTER |
What this research studies
This research investigates the role of the Notch2 pathway in the activation and differentiation of B cells, which are crucial for producing antibodies. By exploring how Notch2 influences B cell division and their readiness to become antibody-secreting plasma cells, the project aims to enhance our understanding of immune responses, particularly in relation to SARS-CoV-2. The study will utilize various laboratory techniques to analyze B cell behavior and responses to viral immunogens, potentially leading to improved vaccine strategies.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals who have been vaccinated against SARS-CoV-2 and are interested in understanding their immune response.
Not a fit: Patients who are not vaccinated against SARS-CoV-2 or those with pre-existing conditions that severely impair their immune system may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective vaccines that generate robust and long-lasting antibody responses against rapidly mutating viruses like SARS-CoV-2.
How similar studies have performed: Previous research has shown that understanding B cell activation pathways can lead to significant advancements in vaccine development, indicating that this approach has potential for success.
Where this research is happening
Philadelphia, United States
- University of Pennsylvania — Philadelphia, United States (Active)
Researchers
- Principal investigator: Londregan, Jennifer — University of Pennsylvania
- Study coordinator: Londregan, Jennifer
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.